Cellular Pharmacology of Cyclopentenyl Cytosine in Molt-4 Lymphoblasts

Cancer Research

Volumn 51, Issue 14, 1991, Pages 3733-3740

  Ford, Harry ^a,b   Cooney, David A ^a   Ahluwalia, Gurpreet S ^a   Hao, Zhang ^a   Rommel, Michael E ^a   Hicks, LeRoi ^a   Dobyns, Kathryn A ^a   Johns, David G ^a  

^a Laboratory of Medicinal Chemistry and Toxicology Branch ^*  (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE;

ARTICLE; HUMAN; HUMAN CELL; LYMPHOBLAST; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE; CYTIDINE; CYTIDINE TRIPHOSPHATE; DNA; HUMAN; LYMPHOCYTES; PROTEINS; RNA;

EID: 0025768070     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lim, M-I., Moyer, J. D., Cysyk, R. L., and Marquez, V. E. Cyclopentenylur-idine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase. J. Med. Chem., 27: 1536-1538, 1984.
2. Marquez, V. E., Lim, M-I., Treanor, S. P., Plowman, J., Priest, M. A., Markovac, A., Khan, M. S., Kaskar, B., and Driscoll, J. S. Cyclopentenyl-cytosine. A carbocyclic nucleoside with antitumor and antiviral properties. J. Med. Chem., 31: 1687-1694, 1988.
3. Kang, G. J., Cooney, D. A., Moyer, J. D., Kelley, J. A., Kim, H-Y., Marquez, V. E., and Johns, D. G. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase. J. Biol. Chem., 264:713-718,1989.
4. Cooney, D. A., Rommel, M. E., Kang, G., Wilson, Y., Tseng, J., and Johns, D. G. Cellular pharmacology in human cells of cyclopentenyl cytosine, a new antineoplastic nucleoside. Proc. Am. Assoc. Cancer Res., 31: 421, 1990.
5. Yoshikawa, M., Kato, T., and Takenishi, T. A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett., 50: 5065-5068, 1967.
6. Cooney, D. A., Dalai, M., Mitsuya, H., McMahon, J. B., Nadkami, M., Balzarini, J., Broder, S., and Johns, D. G. Initial studies on the cellular pharmacology of 2/,3/-dideoxycytidine. Biochem. Pharmacol., 35: 2065-2068, 1986.
7. Reiss, P. D., Zuurendonk, P. F., and Todd, K. Measurement of tissue purine, pyrimidine, and other nucleotides by radial compression high-performance liquid chromatography. Anal. Biochem., 140:162-171, 1984.
8. Garrett, C., and Santi, D. V. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal. Biochem., 99:268-273,1979.
9. Lowry, O. H., Roberts, N. R., Leiner, K. Y., Wu, M. L., and Farr, A. L. The quantitative histochemistry of brain. J. Biol. Chem., 207: 1-16, 1954.
10. Plagemann, P. G. W., Wohlhueter, R. M., and Wolffendin, C. Nucleoside and nucleobase transport in animal cells. Biochim. Biophys. Acta, 947:405-443, 1988.
11. Lauzon, G. J., Paran, J. H., and Paterson, A. R. P. Formation of 1-0-d-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells. Cancer Res., 38: 1723-1729, 1978.
12. Lauzon, G. J., Paterson, A. R. P., and Belch, A. W. Formation of 1-0-d-arabinofuranosyl cytosine diphosphate choline in neoplastic and normal cells. Cancer Res., 38: 1730-1733, 1978.
13. Cooney, D. A., Chisena, C., Carpen, M., Hao, Z., Ahluwalia, G., Baker, D. C., Pemo, C-F., and Johns, D. G. 2,3-Dideoxycytidine-diphosphocholine and 2',3'-dideoxycytidinediphosphoethanolamine: phosphodiester metabolites of the anti-HIV agent 2',3'-dideoxycytidine. Proc. Am. Cancer Res., 30:592, 1989.
14. Glazer, R. I., Cohen, M. B., Hartman, K. D., Knode, M. C., Lim, M-I., and Marquez, V. E. Induction of differentiation in the human promyelocytic leukemic cell line HL-60 by the cyclopentenyl analogue of cytidine. Biochem. Pharmacol., 35:1841-1848, 1986.
15. Yang, J-L., Cheng, E. H., Capizzi, R. L., Cheng, Y-C., and Kute, T. Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia. J. Clin. Invest., 75: 141-146, 1985.
16. Gandhi, V., and Plunkett, W. Interaction of arabinosyl nucleotides in K562 human leukemia cells. Biochem. Pharmacol., 38:3551-3558, 1989.
17. Balzarini, J., Cooney, D. A., Dalai, M., Kang, G-J., Cupp, J. E., De Clercq, E., Broder, S., and Johns, D. G. 2\3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. Mol. Pharmacol., 32: 798-806, 1987.
18. Heinemann, V., Hertel, L. W., Grindey, G. B., and Plunkett, W. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-0-D-arabinofuranosylcytosine. Cancer Res., 48:4024-4031, 1988.
19. Glazer, R. I., Knode, M. C., Lim, M-I., and Marquez, V. E. Cyclopentenyl cytidine analogue: an inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells. Biochem. Pharmacol., 34: 2535-2539, 1985.
20. Valentin-Hansen, P. Uridine-cytidine kinase from Escherichia coli. Methods Enzymol., 51: 308-321, 1978.
21. Nygaard, P., and Sundstrom, C. Low cytidine deaminase levels in human hematopoietic cell lines Leuk. Res., 11:681-685, 1987.
22. Grem, J. L., and Allegra, C. L. Mechanism of action of cyclopentenyl cytosine and biochemical molulation of cytosine arabinoside. Proc. Am. Assoc. Cancer Res., 31:421, 1990.